Dexcom | DXCM - 净收入



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 34.79B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


净收入 更改 日
Abbott USD 928M 149M 2026-06
Align Technology USD 108.29M 4.48M 2026-06
AtriCure USD 8.96M 8.85M 2026-06
Baxter International USD 126M 141M 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Boston Scientific USD 907M 434M 2026-06
Cooper Companies USD -77.9M 208.7M 2026-03
Dexcom USD 249.1M 49.6M 2026-06
Edwards Lifesciences USD 241.9M 138.8M 2026-06
Globus Medical USD 151.57M 27.27M 2026-06
Inogen USD -5.96M 373K 2024-09
Insulet USD 95M 3.9M 2026-06
Integra LifeSciences USD 4.48M 9.1M 2026-06
J&J USD 5.53B 299M 2026-06
Medtronic USD 1.24B 100M 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Roche Holding CHF 6.87B 1.4B 2026-06
Solventum Corp USD 92M 79M 2026-06
Stryker USD 1.28B 531M 2026-06
Tandem Diabetes Care USD -21.17M 775K 2026-06
Teleflex USD 99.69M 107.85M 2026-06
West Pharmaceutical Services USD 154M 15.2M 2026-06
Zimmer Biomet Holdings USD 198.3M 39.8M 2026-06